The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krylova Yu.S.

Saint Petersburg Research Institute of Phthisiopulmonology;
First Saint Petersburg State Medical University named after. acad. I.P. Pavlov (Pavlov University)

Dokhov M.A.

St. Petersburg Research Institute of Phthisiopulmonology;
St. Petersburg State Pediatric Medical University

Panfilova A.S.

St. Petersburg Research Institute of Phthisiopulmonology

Vinogradova T.I.

St. Petersburg Research Institute of Phthisiopulmonology

Mokrousov I.V.

St. Petersburg Pasteur Institute

Kvetnoy I.M.

St. Petersburg Research Institute of Phthisiopulmonology;
St. Petersburg State University

Molecular markers of M. tuberculosis virulence in lung tissue (experimental study)

Authors:

Krylova Yu.S., Dokhov M.A., Panfilova A.S., Vinogradova T.I., Mokrousov I.V., Kvetnoy I.M.

More about the authors

Read: 1094 times


To cite this article:

Krylova YuS, Dokhov MA, Panfilova AS, Vinogradova TI, Mokrousov IV, Kvetnoy IM. Molecular markers of M. tuberculosis virulence in lung tissue (experimental study). Russian Journal of Archive of Pathology. 2024;86(4):31‑37. (In Russ.)
https://doi.org/10.17116/patol20248604131

Recommended articles:
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55

References:

  1. World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27—29 October 2020. Geneva: World Health Organization; 2021.
  2. Chakaya J, Khan M, Ntoumi F, Aklillu E, Razia F, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, et al. Global Tuberculosis Report 2020 — reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113 (suppl 1):S7-S12.  https://doi.org/10.1016/j.ijid.2021.02.107
  3. Fu B, Xue W, Zhang H, Zhang R, Feldman K, Zhao Q, Zhang S, Shi L, Pavani KC, Nian W, et al. MicroRNA-325-3p facilitates immune escape of mycobacterium tuberculosis through targeting LNX1 via NEK6 accumulation to promote anti-apoptotic STAT3 signaling. mBio. 2020;11(3):e00557-20.  https://doi.org/10.1128/mBio.00557-20
  4. Khawbung JL, Nath D, Chakraborty S. Drug resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis. 2021;74:101574. https://doi.org/10.1016/j.cimid.2020.101574
  5. Mokrousov I, Vyazovaya A, Pasechnik O, Gerasimova A, Dymova M, Chernyaeva E, Tatarintseva M, Stasenko V. Early ancient sublineages of Mycobacterium tuberculosis Beijing genotype: unexpected clues from phylogenomics of the pathogen and human history. Clin Microbiol Infect. 2019;25(8):1039.e1-1039.e6.  https://doi.org/10.1016/j.cmi.2018.11.024
  6. Vinogradova T, Dogonadze M, Zabolotnykh N, Badleeva M, Yarusova I, Vyazovaya A, Gerasimova A, Zhdanova S, Vitovskaya M, Solovieva N, Pasechnik O, Ogarkov O, Mokrousov I. Extremely lethal and hypervirulent Mycobacterium tuberculosis strain cluster emerging in Far East, Russia. Emerg Microbes Infect. 2021;10(1):1691-1701. https://doi.org/10.1080/22221751.2021.1967704
  7. Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr. 2019;7(4):10.1128/microbiolspec.GPP3-0022-2018. https://doi.org/10.1128/microbiolspec.GPP3-0022-2018
  8. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. New Engl J Med. 2001;345(15):1098-1104. https://doi.org/10.1056/NEJMoa011110
  9. Tallerico R, Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, et al. Human NK cells selective targeting of colon cancer — initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol. 2013;190(5):2381-2390. https://doi.org/10.4049/jimmunol.1201542
  10. Boni FG, Hamdi I, Koundi LM, Shrestha K, Xie J. Cytokine storm in tuberculosis and IL-6 involvement. Infect Genet Evol. 2022;97:105166. https://doi.org/10.1016/j.meegid.2021.105166
  11. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol. 2009;130(1):27-33.  https://doi.org/10.1016/j.clim.2008.08.018

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.